Content-Length: 66122 | pFad | https://app.mc.uky.edu/mcctrials/cancer/melanoma
| Protocol No. | Title |
|---|---|
| ATRIUM-ICI-M1201 | ATRIUM-ICI-M1201: AbatacepT foR ImmUne checkpoint inhibitor associated Myocarditis (ATRIUM): A Phase 3, Investigator-Initiated, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Abatacept Compared to Placebo in Hospitalized Participants with Immune Checkpoint Inhibitor Associated Myocarditis |
| MCC-16-MULTI-18-PMC | Genomic Testing for Patients with Refractory Cancer to Determine Treatment |
| MCC-16-MULTI-19-PMC | Evaluating Genomic Testing in Human Cancer & Outcomes of Targeted Therapies |
| MCC-17-MTB-01-PMC | MCC-17-MTB-01-PMC: Total Cancer Care Protocol: A Lifetime Partnership with Patients Who Have or May be at Risk of Having Cancer |
| MCC-20-MEL-11-PMC | Nilotinib+Dabrafenib+Trametinib in BRAF V600 Mutant Metastatic Melanoma after Progression |
| MCC-23-MULTI-61 | Comprehensive Connected Cancer Care (C4): Intervention Evaluation |
| NCI-CIRB-APEC14B1 | Project:EveryChild |
| NCI-CIRB-APEC1621-SC | Pediatric MATCH - Screening Protocol |
| NMTRC014 | Difluoromethylornithine for Neuroblastoma Maintenance Therapy |
| Protocol No. | Title |
|---|---|
| ATRIUM-ICI-M1201 | ATRIUM-ICI-M1201: AbatacepT foR ImmUne checkpoint inhibitor associated Myocarditis (ATRIUM): A Phase 3, Investigator-Initiated, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Abatacept Compared to Placebo in Hospitalized Participants with Immune Checkpoint Inhibitor Associated Myocarditis |
| MCC-16-MULTI-18-PMC | Genomic Testing for Patients with Refractory Cancer to Determine Treatment |
| MCC-16-MULTI-19-PMC | Evaluating Genomic Testing in Human Cancer & Outcomes of Targeted Therapies |
| MCC-17-MTB-01-PMC | MCC-17-MTB-01-PMC: Total Cancer Care Protocol: A Lifetime Partnership with Patients Who Have or May be at Risk of Having Cancer |
| MCC-20-MEL-11-PMC | Nilotinib+Dabrafenib+Trametinib in BRAF V600 Mutant Metastatic Melanoma after Progression |
| MCC-23-MULTI-61 | Comprehensive Connected Cancer Care (C4): Intervention Evaluation |
| NCI-CIRB-APEC14B1 | Project:EveryChild |
| NCI-CIRB-APEC1621-SC | Pediatric MATCH - Screening Protocol |
| NMTRC014 | Difluoromethylornithine for Neuroblastoma Maintenance Therapy |
| Protocol No. | Title |
|---|---|
| NCI-CIRB-APEC14B1 | Project:EveryChild |
| NCI-CIRB-APEC1621-SC | Pediatric MATCH - Screening Protocol |
| NMTRC014 | Difluoromethylornithine for Neuroblastoma Maintenance Therapy |
Fetched URL: https://app.mc.uky.edu/mcctrials/cancer/melanoma
Alternative Proxies: